Facebook
Linkedin
Youtube
X-twitter
Instagram
Professional Syndicates Complex, Sharif Abdel Hamid Sharaf Street, 31, Amman, Jordan
About Jordan
Home
Membership
Membership Request
Associate Members
Types of memberships
General Payment Service via Cliq
Activity
Lectures and conferences
Health Education
Scientific materials
Gallary
Videos
Photos
About US
Contact us
English
Arabic
Login
Home
Membership
Membership Request
Associate Members
Types of memberships
General Payment Service via Cliq
Activity
Lectures and conferences
Health Education
Scientific materials
Gallary
Videos
Photos
About US
Contact us
English
Arabic
من نحن
تاريخ الجمعية
هيكل الجمعية
ادارة الجمعية
تطوع معنا
العضوية
طلب انتساب
الاعضاء المنتسبون
Types of memberships in the Society of Cardiologists
Home
نشاطات
مواد علمية
Health Education
جاليري
فيديو
صور
اتصل بنا
Valvular heart diseases
Cardiac Arrythmias
Cardiomyopathy
Congestive heart failure
ECG (EKG)
Hypertension
Infective endocarditis
ISCHEMIA
Pericarditis
مجلة أبحاث أمراض القلب والأوعية الدموية
MORTALITY OF CARDIOVASCULAR DISEASES IN GAZA DURING THE ISRAELI MILITARY OPERATION
There's no evidence to support A. Stopping DOACS 4, 5, or 7 days as some surgeons recommend. B. Bridging with LMWH.
Take-home-message
ESC - European Society of Cardiology
Summaries about chest pain units
الرسالة الأساسية من الدراسه - Take Home Message
Chest Pain Risk Stratification in the Emergency Department: Current Perspectives
ECG features increasing the likelihood of VT
Top 10 Take-Home Messages FROM THE AHA 24
New AI program delivers rapid, accurate echo video assessments Michael Walter| December 12, 2024
FDA approves new short term treatment for Afib atrial flutter in critical care settings
Protocol for the Management of Acute Chest Pain in ER
Chest Pain Management in Ambulance: Guidelines
There are established protocols for managing chest pain in the emergency department
Standardizing Diagnosis and “Management of Acute Myocarditis Progress:Through End of 2024
Harmony TPVR System Gains CE Mark Approval
Heart Valve Replacement Options for Heart Disease
FDA has now cleared more than 1,000 AI models, including many in cardiology January 10, 2025 |
New AI program delivers rapid, accurate echo video assessments
Renal Denervation for Uncontrolled Hypertension
Exploring the ‘New Era’ of HFpEF Treatment: More Options Exist, but Challenges Remain. January 14, 2025
By the end of 2024 TAVR studies
Comprehensive Summary of the Article: “PET-CT Seeing Increasing Adoption, and Now More Affordable Systems Have Facilities Taking a Closer Look
The use of intracardiac echocardiography (ICE) has gained significant traction in recent years
New AI model uses ECG images to evaluate heart failure risk. a multinational study in European Heart Journal.
Bioprosthetic vs. Mechanical Aortic Valve Replacement in Patients Aged 40-7
Summary of the Article: Be Good to Your Teeth: Regular Flossing Reduces Risk of Stroke, AFib February 4, 2025
recent advancements in the treatment of heart failure with preserved ejection fraction (HFpEF) -January 14, 2025.
AVR for Asymptomatic Severe AS 13 Feb 2025. JAMA Cardiology
A study published in The Annals of Thoracic Surgery found that robotic-assisted mitral valve repair has short-term outcomes comparable to conventional surgery
Key Takeaways: Interventional Heart Failure (IHF) as an Emerging Subspecialty 11 Feb 2025.
Key Takeaways 12 Feb 2025: Proposed American Board of Cardiovascular Medicine (ABCVM)
JACC | Jan 25, 2025Mechanical Heart Valves Lead to Superior Long-Term Outcomes in SAVR for Patients 60 and Younger
Advancing Cardiac Prevention: James Min’s Vision February 20, 2025
February 19, 2025 – Key Messages Sweetener aspartame aggravates atherosclerosis
Home Messages: CABG vs. PCI in Patients with TVD and CKD
Key Takeaways: AI-Guided Decision for LAAO vs. DOAC in AFib Patients
Ischemic risk after PCI is assessed using clinical, procedural, and angiographic factors. Several scoring systems and risk models help guide DAPT duration and intensity based on ischemic vs. bleeding risk.
New Directions and Trends in Interventional Cardiology
AVR for Asymptomatic Severe AS 13 Feb 2025. JAMA Cardiology .
A study published in The Annals of Thoracic Surgery
Key Takeaways: Interventional Heart Failure (IHF) as an Emerging Subspecialty 11 Feb 2025.
Key Takeaways 12 Feb 2025:Proposed American Board of Cardiovascular Medicine (ABCVM)
Key Takeaways from JACC: (February 5th 2025 ) Beta-Blockers and Broken heart syndrome “Takotsubo Syndrome(TTS)”
Summary: Alternative Access Options for TAVR
The 2025 ACC/AHA guidelines for managing acute coronary syndromes (ACS) have introduced several updates compared to previous guidelines.
Summary: AI-Driven CCTA Imaging for Coronary Inflammation Detection. This post was featured in the American Heart Association (AHA) publications. February 26, 2025
STEMI Reperfusion Pathway: From EMS-Prehospital Diagnosis to Definitive Treatment”. This post is currently under review by the Chest Pain Protocol Task Force.
Prehospital/EMS and Hospital Reperfusion Time Goals for STEMI in 2025 ACS AHA/ACC guidelines:
Summary of the ACC/AHA 2025 ACS Guidelines Update
Highlights: Comparison of ESC vs. ACC/AHA ACS Guidelines
Summary of the Historic Living Mitral Valve Replacement
Why Cardiac CT Adoption Remains Low Among Primary Care Providers
FDA Clears Google Smartwatch Feature for Emergency Heart Monitoring
Key Points from AHA Publications on AI in Cardiology (Published in March 04 2025)
Sotagliflozin Significantly Reduces Cardiovascular Risk in high risk patients.
CABG still the ‘gold standard’ for revascularization in patients with 3-vessel CAD and CKD.
Advancing Cardiac Prevention: James Min’s Vision
JACC | Jan 25, 2025Mechanical Heart Valves Lead to Superior Long-Term Outcomes in SAVR for Patients 60 and Younger
TAVR Linked to Stronger Valve Performance Than SAVR in New 5-Year Study
TAVR in Africa: High Success Rate but Above-Average Risks
Patient Discharged with Total Artificial Heart for the First Time—105 Days Before Transplant
Trends in Diagnostic Heart Testing : CT on the Rise as Some Traditional Techniques Decline
Exploring the Little Brain in the Heart: A Journey into Heart-Brain Communication
Summary: Decline in Heart Failure-Related Cardiac Arrest Mortality, but Disparities Persist
Artificial intelligence (AI) offers several avenues to make healthcare more affordable. March 06, 2025 | AI in Healthcare
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults and Special Considerations in Pulmonary Hypertension
Early TAVR or SAVR for asymptomatic severe AS limits strokes, hospitalizations.
In a European population-based cohort study, the lifetime risk of incident HFrEF was higher in men, while women were at greater risk of developing HFpEF
Hypertension Updated 2024
Key Points from AHA Publications on AI in Cardiology (Published in March 04 2025)
Cardiologists Make History with World’s First Robotic trancatheter mitral valve replacement (TMVR) Procedures
Current guidelines for the use of CT calcium scoring in preventive cardiology
Lp(a) and LDL-c are independent and Additive Predictors of ASCVD Risk
The American Heart Association (AHA) has highlighted several strategies for managing elevated lipoprotein(a) [Lp(a)]
Finerenone’s Effects in HFmrEF/HFpEF and Obesitye
An Evolving Strategy in Stroke Prevention in patients with nonvalvular(AF)
Will AI Help or Hurt Healthcare Equality?
AI’s Growing Role in Cardiovascular Imaging & Interventional Cardiology
Newborns with Congenital Heart Defects Face Elevated Cancer Risk
Mitral Valve Repair vs. Replacement in Infective Endocarditis.
Advancements in RF Technology: Enhancing Care and Workflow Efficiency at Texas Cardiac Arrhythmia Institute
Advances in Bioresorbable Stents for Treating PAD
AI-Assisted Mammography Identifies Cardiovascular Risk: Key Findings
Key Takeaways: 5-Year Data on TAVR for Failing Surgical Valves
TAVR for failing surgical valves: Lessons learned from new 5-year data
FDA Class I Recall of Bard Peripheral Vascular’s Rotarex Atherectomy System
FDA Class I Recall of Bard Peripheral Vascular’s Rotarex Atherectomy System
Summary of Vutrisiran (Amvuttra) FDA Approval of amyloid cardiomyopathy (ATTR-CM).
Summary of RF Ablation Advancements – Texas Cardiac Arrhythmia Institute
TAVR for failing surgical valves: Lessons learned from new 5-year data
A new drug, ataciguat, has shown promise in Treating Aortic Stenosis & slowing the progression of aortic stenosis (AS) and potentially reducing the need for TAVR or SAVR procedures.
Key Trends in Transcatheter Tricuspid Valve Interventions
Summary of Study on Heart Failure-related Cardiac Arrest Mortality
the SWEDEHEART
Key TAVR Highlights at ACC.25
New Scanners and Strategies for the ‘Golden Age of CCTA’
A Glass of Orange Juice a Day May Help Keep the Cardiologist Away
Timing is Everything: Delaying Noncardiac Surgery After a Heart Procedure Reduces Risks
Food Insecurity Increases Risk of Poor Heart Health in Young Adults
FDA Recognizes AI Model for Heart Attack Detection
Summary: A Glass of Orange Juice a Day May Help Keep the Cardiologist Away
Challenges of pharmacological Treatment and Management of Hyperkalemia in Patients on RAAS Inhibitors – ESC Congress 2025 Highlights
Interventional heart failure: An evolving cardiology subspecialty with a bright future
The Role of Icosapent Ethyl in Cardiovascular Risk Reduction. Highlighted by AHA
The Role of Maintaining Lower LDL-C Level During Statin Treatment for Advanced CKD Patients
Plant-Based Diets and Longevity in Patients with Cardiometabolic Disorders
Summary of the New tricuspid repair ( T-TEER )
A Groundbreaking Surgery
New TAVR Research Explores Adverse Outcomes, Disease Progression in Patients with Asymptomatic Severe AS
Key takeaways from ACC.25: Advances in cardiovascular science
Summary of “Optimal DAPT Duration in Patients With High and Low Bleeding Risk?”
The issue of optimal treatment of Hyperkalemia in a patient with CHF treated with MRA should be cautious.
API-CAT Trial. ACC 2025
Efficacy Of Rivaroxaban Versus Warfarin In Patients With Acute Left Ventricular Thrombus Following Myocardial Infarction: RIVAWAR Trial
Choosing left radial access in the Cath lab helps cardiologists limit radiation exposure
Recent advancements have enhanced the detection of left atrial appendage (LAA) thrombi in patients with atrial fibrillation (AF), offering alternatives to transesophageal echocardiography (TEE)
Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial Reported from ACC
LV thrombus
Key Takeaways from ACC.25: Advances in Cardiovascular Science
Today’s News and Trends in Cardiology highlighted by AHA/ACC:
ASE Releases Updated Guidelines for Right Heart Echocardiographic Assessment in Pulmonary Hypertension
The Role of Each Cardiac Imaging Modality (Echocardiography, Cardiac CT, Cardiac MRI, and Nuclear Imaging) in Evaluating Five Cardiac Conditions: Cardiomyopathy (CMP), Aortic Stenosis (AS), Mitral Regurgitation (MR), Tricuspid Regurgitation (TR), and Constrictive Pericarditis
Effect of Frailty on Intensive Blood Pressure Lowering in Hypertensive Patients at High Cardiovascular Risk – Post-hoc Analysis of the ESPRIT Trial
Does Intensive Systolic Blood Pressure (SBP) Control Reduce Cardiovascular Mortality in U.S. Adults Aged 80+?
ACC.25 – ALLEPRE Study: Nurse-Coordinated Prevention Program Improves Outcomes and Reduces MACE Risk in High-Risk ACS Patients
Summary: REVERSE-IT Trial – ACC.25 (Reversal if Ticagrelor’s Antiplatelet Effects in Urgent Surgery or Major Bleeding) Source: ACC.25 Scientific Session, presented by Dr. Deepak Bhatt (New York, NY, USA) Date: March 2025
ACC.25 – ALLEPRE Study: Nurse-Coordinated Prevention Program Improves Outcomes and Reduces MACE Risk in High-Risk ACS Patients
Fluid Restriction Does Not Improve outcomes in Chronic HF.
Summary: First-in-Man Study Shows Promising Results for world’s first TAVR procedure New Fully Retrievable Valve.
Shockwave Medical Co. Launches First-in-Patient Study of Forward IVL Technology for Challenging Calcified Coronary Lesions:
Summary of Late-Breaking Drug Trials at ACC.25 , major breakthroughs in cardiovascular pharmacology were presented
Summary: “Is statin therapy safe for pregnant women?”
Cardiac Arrest During MRI Highlights the Importance of Patient Monitoring
Nurses Developing Mysterious Brain Tumors
TAVR for pure aortic regurgitation performs well.
Right heart cardiac ultrasound contrast agent for shunts enters U.S. trial ASI-O2. Highlighted by MDPI. April 09, 2025
Why researchers believe silver nanoparticles could ‘revolutionize’ medical imaging.
Why Some Patients Are More Susceptible to side effects in patients who have been given gadolinium during MRI exams.
Clinical Safety of Contrast Agents in CT and MRI: Renal Risk, Agent Selection, and Practical Guidelines
Predicting Bleeding Risk in AF Patients Using AI (Smart Computer Tools).
Ventricular premature beats
Valvular heart diseases
Tachyarrythmias & Bradyarrythmias &Atrial fibrillation
Peripheral arterial disease
Pericarditis and cardiac tamponade
ISCHEMIA HEART DISEASES (CAD)
Infective endocarditis
Hypertesion
ECG1
CPR, general principles
Congestive heart failure
Cardiovascular Examination lecture
Cardiomyopathy
Cardiac history
Beta Blockers - Formulation to Clinical 2024
Atrial fibrillation
Aortic dissection
Search for:
Search Button